首页> 外国专利> PHARMACEUTICAL COMPOSITION FORMED ORAL ADMINISTRATION UNDERSTANDING A LAYER UNDERSTANDING A MODIFIED RELEASE PART AND A LAYER UNDERSTANDING AN IMMEDIATE RELEASE PART

PHARMACEUTICAL COMPOSITION FORMED ORAL ADMINISTRATION UNDERSTANDING A LAYER UNDERSTANDING A MODIFIED RELEASE PART AND A LAYER UNDERSTANDING AN IMMEDIATE RELEASE PART

机译:理解为修饰的释药部分的层和立即释药的层的药物成分

摘要

A pharmaceutical composition formulated for oral administration comprising a layer comprising a modified release portion and a layer comprising an immediate release portion. The present invention relates to a pharmaceutical composition for oral administration comprising a modified release portion containing tamsulosin or a pharmaceutically acceptable salt thereof. same, and an immediate release moiety containing solifenacin or a pharmaceutically acceptable salt thereof and a hydrophilic substance. In the pharmaceutical composition, the dissolution rate of each drug (in particular, solifenacin contained in the immediate release portion) is similar to that of current single drug formulations and the maximum percentage of dissolution of each drug (in particular, solifenacin contained in the portion of immediate release). immediate release) is 90% or more. therefore, the pharmaceutical composition is a single formulation (i.e. a combined formulation) with a bioavailability equivalent to that of current single drug formulations.
机译:配制用于口服给药的药物组合物,其包含包含调释部分的层和包含速释部分的层。本发明涉及用于口服给药的药物组合物,其包含含有坦索罗辛或其药学上可接受的盐的调释部分。相同的化合物,以及含有索非那新或其药学上可接受的盐和亲水性物质的速释部分。在药物组合物中,每种药物(特别是速释部分中所含的索非那新)的溶出速率与当前的单一药物制剂的溶出速率相似,并且每种药物(特别是该部分中所含的索非那新)的最大溶出百分比相似。立即发布)。立即发布)为90%或更高。因此,药物组合物是具有与当前单一药物制剂相同的生物利用度的单一制剂(即组合制剂)。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号